The System Was Designed Backwards
Modern medicine looks advanced.
Precision molecules. Billion-dollar trials. AI-driven discovery.
And yet, when the drug finally reaches the patient, it often arrives in a format invented for industrial convenience in the 19th century.
A compressed solid.
A tablet.
The uncomfortable truth is this:
Pharmaceutical systems are optimised for manufacturing efficiency—not human biology.
The Original Constraint
Tablets solved a critical problem:
- Standardisation
- Stability
- Scalability
They enabled companies like Pfizer and Bayer to industrialise medicine.
But that constraint—how do we mass-produce drugs?—became the dominant design principle.
Not:
- How do we maximise absorption?
- How do we personalise dosing?
- How do we improve patient experience?
The Cost of Convenience
Every tablet asks the body to do the hard work:
- Disintegrate
- Dissolve
- Absorb
Each step introduces failure.
- Variable gastric conditions
- Food interactions
- Patient-specific physiology
For millions of people with Dysphagia, the system fails before it even begins.
The Inversion
In every other industry, systems evolve toward the user.
- Interfaces become intuitive
- Products adapt to behaviour
- Friction is eliminated
Pharma did the opposite.
We built a system where the patient adapts to the product.
The Inevitable Shift
The next era of medicine will invert the model:
- From compression → absorption
- From standardisation → precision
- From manufacturing-first → human-first
Ibumix exists at that inflection point.
Not improving the pill.
Replacing the assumption that it should exist.